|
1
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao M, Monian P, Quadri N, Ramasamy R and
Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol
Cell. 59:298–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang WS and Stockwell BR: Ferroptosis:
Death by lipid peroxidation. Trends Cell Biol. 26:165–176. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Skouta R, Dixon SJ, Wang J, Dunn DE, Orman
M, Shimada K, Rosenberg PA, Lo DC, Weinberg JM, Linkermann A and
Stockwell BR: Ferrostatins inhibit oxidative lipid damage and cell
death in diverse disease models. J Am Chem Soc. 136:4551–4556.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Linkermann A, Skouta R, Himmerkus N, Mulay
SR, Dewitz C, De Zen F, Prokai A, Zuchtriegel G, Krombach F, Welz
PS, et al: Synchronized renal tubular cell death involves
ferroptosis. Proc Natl Acad Sci USA. 111:16836–16841. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bai T, Wang S, Zhao Y, Zhu R, Wang W and
Sun Y: Haloperidol, a sigma receptor 1 antagonist, promotes
ferroptosis in hepatocellular carcinoma cells. Biochem Biophys Res
Commun. 491:919–925. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sauzay C, Louandre C, Bodeau S, Anglade F,
Godin C, Saidak Z, Fontaine JX, Usureau C, Martin N, Molinie R, et
al: Protein biosynthesis, a target of sorafenib, interferes with
the unfolded protein response (UPR) and ferroptosis in
hepatocellular carcinoma cells. Oncotarget. 9:8400–8414. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hao S, Yu J, He W, Huang Q, Zhao Y, Liang
B, Zhang S, Wen Z, Dong S, Rao J, et al: Cysteine dioxygenase 1
mediates erastin-induced ferroptosis in human gastric cancer cells.
Neoplasia. 19:1022–1032. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jennis M, Kung CP, Basu S, Budina-Kolomets
A, Leu JI, Khaku S, Scott JP, Cai KQ, Campbell MR, Porter DK, et
al: An african-specific polymorphism in the TP53 gene impairs p53
tumor suppressor function in a mouse model. Genes Dev. 30:918–930.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu S, Zhang Q, Sun X, Zeh HJ III, Lotze
MT, Kang R and Tang D: HSPA5 regulates ferroptotic cell death in
cancer cells. Cancer Res. 77:2064–2077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi Y, Kasukabe T and Kumakura S:
Piperlongumine rapidly induces the death of human pancreatic cancer
cells mainly through the induction of ferroptosis. Int J Oncol.
52:1011–1022. 2018.PubMed/NCBI
|
|
16
|
Stipanuk MH, Ueki I, Dominy JE Jr, Simmons
CR and Hirschberger LL: Cysteine dioxygenase: A robust system for
regulation of cellular cysteine levels. Amino acids. 37:55–63.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Khoo KH, Verma CS and Lane DP: Drugging
the p53 pathway: Understanding the route to clinical efficacy. Nat
Rev Drug Discov. 13:217–236. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie Y, Song X, Sun X, Huang J, Zhong M,
Lotze MT, Zeh HJ Rd, Kang R and Tang D: Identification of baicalein
as a ferroptosis inhibitor by natural product library screening.
Biochem Biophys Res Commun. 473:775–780. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong SH, Lee DH, Lee YS, Jo MJ, Jeong YA,
Kwon WT, Choudry HA, Bartlett DL and Lee YJ: Molecular crosstalk
between ferroptosis and apoptosis: Emerging role of ER
stress-induced p53-independent PUMA expression. Oncotarget.
8:115164–115178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J,
Zhong M, Yuan H, Zhang L, Billiar TR, et al: The tumor suppressor
p53 limits ferroptosis by blocking DPP4 activity. Cell Rep.
20:1692–1704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei G, Sun J, Hou Z, Luan W, Wang S, Cui
S, Cheng M and Liu Y: Novel antitumor compound optimized from
natural saponin albiziabioside a induced caspase-dependent
apoptosis and ferroptosis as a p53 activator through the
mitochondrial pathway. Eur J Med Chem. 157:759–772. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C,
Dai X, Li Z and Wu G: Ferroptosis: A novel anti-tumor action for
cisplatin. Cancer Res Treat. 50:445–460. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park S, Oh J, Kim M and Jin EJ: Bromelain
effectively suppresses Kras-mutant colorectal cancer by stimulating
ferroptosis. Anim Cells Syst (Seoul). 22:334–340. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pagliara V, Saide A, Mitidieri E,
d'Emmanuele di Villa Bianca R, Sorrentino R, Russo G and Russo A:
5-FU targets rpL3 to induce mitochondrial apoptosis via
cystathionine-β-synthase in colon cancer cells lacking p53.
Oncotarget. 7:50333–50348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Russo A, Saide A, Smaldone S, Faraonio R
and Russo G: Role of uL3 in multidrug resistance in p53-mutated
lung cancer cells. Int J Mol Sci. 18(pii): E5472017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kasukabe T, Honma Y, Okabe-Kado J, Higuchi
Y, Kato N and Kumakura S: Combined treatment with cotylenin A and
phenethyl isothiocyanate induces strong antitumor activity mainly
through the induction of ferroptotic cell death in human pancreatic
cancer cells. Oncol Rep. 36:968–976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eling N, Reuter L, Hazin J, Hamacher-Brady
A and Brady NR: Identification of artesunate as a specific
activator of ferroptosis in pancreatic cancer cells. Oncoscience.
2:517–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mancias JD, Wang X, Gygi SP, Harper JW and
Kimmelman AC: Quantitative proteomics identifies NCOA4 as the cargo
receptor mediating ferritinophagy. Nature. 509:105–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shintoku R, Takigawa Y, Yamada K, Kubota
C, Yoshimoto Y, Takeuchi T, Koshiishi I and Torii S:
Lipoxygenase-mediated generation of lipid peroxides enhances
ferroptosis induced by erastin and RSL3. Cancer Sci. 108:2187–2194.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh
HJ III, Kang R and Tang D: Autophagy promotes ferroptosis by
degradation of ferritin. Autophagy. 12:1425–1428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Louandre C, Ezzoukhry Z, Godin C, Barbare
JC, Mazière JC, Chauffert B and Galmiche A: Iron-dependent cell
death of hepatocellular carcinoma cells exposed to sorafenib. Int J
Cancer. 133:1732–1742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yuan H, Li X, Zhang X, Kang R and Tang D:
CISD1 inhibits ferroptosis by protection against mitochondrial
lipid peroxidation. Biochem Biophys Res Commun. 478:838–844. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Geldenhuys WJ, Leeper TC and Carroll RT:
mitoNEET as a novel drug target for mitochondrial dysfunction. Drug
Discov Today. 19:1601–1606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ou W, Mulik RS, Anwar A, McDonald JG, He X
and Corbin IR: Low-density lipoprotein docosahexaenoic acid
nanoparticles induce ferroptotic cell death in hepatocellular
carcinoma. Free Radic Biol Med. 112:597–607. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sporn MB and Liby KT: NRF2 and cancer: The
good, the bad and the importance of context. Nat Rev Cancer.
12:564–571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jaramillo MC and Zhang DD: The emerging
role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev.
27:2179–2191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ren D, Villeneuve NF, Jiang T, Wu T, Lau
A, Toppin HA and Zhang DD: Brusatol enhances the efficacy of
chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
Proc Natl Acad Sci USA. 108:1433–1438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang Z, Yao Z, Wang L, Ding H, Shao J,
Chen A, Zhang F and Zheng S: Activation of ferritinophagy is
required for the RNA-binding protein ELAVL1/HuR to regulate
ferroptosis in hepatic stellate cells. Autophagy. 14:2083–2103.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hayashi T and Su TP: Sigma-1 receptor
chaperones at the ER-mitochondrion interface regulate Ca(2+)
signaling and cell survival. Cell. 131:596–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kourrich S, Hayashi T, Chuang JY, Tsai SY,
Su TP and Bonci A: Dynamic interaction between sigma-1 receptor and
Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell.
152:236–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dehart DN, Fang D, Heslop K, Li L,
Lemasters JJ and Maldonado EN: Opening of voltage dependent anion
channels promotes reactive oxygen species generation, mitochondrial
dysfunction and cell death in cancer cells. Biochem Pharmacol.
148:155–162. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Louandre C, Marcq I, Bouhlal H, Lachaier
E, Godin C, Saidak Z, François C, Chatelain D, Debuysscher V,
Barbare JC, et al: The retinoblastoma (Rb) protein regulates
ferroptosis induced by sorafenib in human hepatocellular carcinoma
cells. Cancer Lett. 356:971–977. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cao W, Hou FF and Nie J: AOPPs and the
progression of kidney disease. Kidney Int Suppl (2011). 4:102–106.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Houessinon A, François C, Sauzay C,
Louandre C, Mongelard G, Godin C, Bodeau S, Takahashi S, Saidak Z,
Gutierrez L, et al: Metallothionein-1 as a biomarker of altered
redox metabolism in hepatocellular carcinoma cells exposed to
sorafenib. Mol Cancer. 15:382016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun X, Niu X, Chen R, He W, Chen D, Kang R
and Tang D: Metallothionein-1G facilitates sorafenib resistance
through inhibition of ferroptosis. Hepatology. 64:488–500. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee YS, Lee DH, Jeong SY, Park SH, Oh SC,
Park YS, Yu J, Choudry HA, Bartlett DL and Lee YJ:
Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through
upregulation of death receptor 5. J Cell Biochem. 120:928–939.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dai Z, Huang Y, Sadee W and Blower P:
Chemoinformatics analysis identifies cytotoxic compounds
susceptible to chemoresistance mediated by glutathione and
cystine/glutamate transport system xc. J Med Chem. 50:1896–1906.
2007. View Article : Google Scholar : PubMed/NCBI
|
